quinine
Megjelenés
| Clinical data | |
|---|---|
| Pronunciation | US: /ˈkwaɪnaɪn/, /kwɪˈniːn/ or UK: /ˈkwɪniːn/ KWIN-een |
| Trade names | Qualaquin, Quinbisul, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682322 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth, intramuscular, intravenous, rectal |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Protein binding | 70–95% |
| Metabolism | Liver (mostly CYP3A4 and CYP2C19-mediated) |
| Elimination half-life | 8–14 hours (adults), 6–12 hours (children) |
| Excretion | Kidney (20%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C20H24N2O2 |
| Molar mass | 324.424 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 177 °C (351 °F) |
| |
| |
| | |
Főnév
quinine (tsz. quinines)